None listed
Conditions
Brief summary
This study is intended to investigate if wearing an activity tracker during inpatient hospital stay impacts the length of inpatient stay, in days. Who is it for? You may be eligible for this study if you are aged at 18-85 years and are undergoing surgery for stomach, liver or pancreatic cancer with one of the participating surgeons involved in this study at the Royal Prince Alfred Hospital and the Chris O'Brien Lifehouse in Sydney. Study details Participants in this study will be randomised (by chance) into two groups. Both groups will undergo their planed surgery procedure. One group will then wear an activity tracker during their inpatient stay in hospital in addition to receiving the usual post operative care, while the other group will not wear an activity tracker but will also receive the usual post-operative care.. All participants will complete a number of questionnaires at 3 timepoints over the weeks just prior to and following their surgery. It is intended that this study will help to improve post-operative care for stomach, liver and/or pancreatic cancer patients in the future.
Interventions
Participants in the intervention group will first complete a baseline questionnaire when they consent to the trial, and provide some personal details and medical history to the study research officer. They will then proceed to their surgery, Participants will given a wearable "Fitbit(TM)" activity tracker to wear throughout their hospital stay, will be verbally encouraged to mobilise (walk around) on the ward by the physiotherapists and will record their daily steps in a log/diary while in hospi
Participants in the intervention group will first complete a baseline questionnaire when they consent to the trial, and provide some personal details and medical history to the study research officer. They will then proceed to their surgery, Participants will given a wearable "Fitbit(TM)" activity tracker to wear throughout their hospital stay, will be verbally encouraged to mobilise (walk around) on the ward by the physiotherapists and will record their daily steps in a log/diary while in hospital. At discharge, the activity tracker will be returned to the research officer. After surgery, intervention participants will complete another 2 post-operative questionnaire at time of discharge from hospital and 30 days after surgery. The control (comparator) group will undergo all these procedures except they will NOT wear an activity tracker during their hospital stay.
Sponsors
Sydney Local Health District
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Healthy volunteers
No
Inclusion criteria
Patients must be adults aged 18-85 years and scheduled to undergo elective surgery for liver, stomach and pancreatic cancer with one of the participating surgeons at the Royal Prince Alfred Hospital, or the Chris O'Brien Lifehouse, Sydney.
Exclusion criteria
Patients will be excluded from participating in this trial if they present: • Cognitive impairment such that they are unable to provide informed consent. • Unable to place a Fitbit on patient’s wrist (including size and/or allergy). • Neurological deficit which requires assistance in mobilisation (e.g. stroke, post limb amputation). • Insufficient English language to complete outcome measures
Outcome results
None listed